nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—P2RY12—cardiovascular system—nicotine dependence	0.06	0.268	CbGeAlD
Treprostinil—Throat irritation—Varenicline—nicotine dependence	0.0499	0.0771	CcSEcCtD
Treprostinil—PPARD—midbrain—nicotine dependence	0.0389	0.174	CbGeAlD
Treprostinil—PTGIR—cardiovascular system—nicotine dependence	0.0383	0.171	CbGeAlD
Treprostinil—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0373	0.0577	CcSEcCtD
Treprostinil—Laryngeal pain—Varenicline—nicotine dependence	0.037	0.0571	CcSEcCtD
Treprostinil—P2RY12—brain—nicotine dependence	0.0294	0.132	CbGeAlD
Treprostinil—Viral infection—Varenicline—nicotine dependence	0.0279	0.0431	CcSEcCtD
Treprostinil—Pulmonary embolism—Varenicline—nicotine dependence	0.0252	0.0389	CcSEcCtD
Treprostinil—PPARD—brain—nicotine dependence	0.0245	0.109	CbGeAlD
Treprostinil—PTGIR—brain—nicotine dependence	0.0188	0.084	CbGeAlD
Treprostinil—Hypokalaemia—Varenicline—nicotine dependence	0.0166	0.0257	CcSEcCtD
Treprostinil—Bronchitis—Varenicline—nicotine dependence	0.0152	0.0235	CcSEcCtD
Treprostinil—Abdominal discomfort—Varenicline—nicotine dependence	0.0152	0.0234	CcSEcCtD
Treprostinil—Depression—Varenicline—nicotine dependence	0.0141	0.0217	CcSEcCtD
Treprostinil—CYP2C9—cardiovascular system—nicotine dependence	0.0137	0.0612	CbGeAlD
Treprostinil—Epistaxis—Varenicline—nicotine dependence	0.0133	0.0205	CcSEcCtD
Treprostinil—Sinusitis—Varenicline—nicotine dependence	0.0132	0.0204	CcSEcCtD
Treprostinil—Bradycardia—Varenicline—nicotine dependence	0.0129	0.0199	CcSEcCtD
Treprostinil—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0128	0.0993	CbGpPWpGaD
Treprostinil—Oedema peripheral—Varenicline—nicotine dependence	0.0125	0.0193	CcSEcCtD
Treprostinil—Erythema—Varenicline—nicotine dependence	0.011	0.017	CcSEcCtD
Treprostinil—Back pain—Varenicline—nicotine dependence	0.0107	0.0165	CcSEcCtD
Treprostinil—Muscle spasms—Varenicline—nicotine dependence	0.0106	0.0164	CcSEcCtD
Treprostinil—Ill-defined disorder—Varenicline—nicotine dependence	0.0102	0.0158	CcSEcCtD
Treprostinil—Anaemia—Varenicline—nicotine dependence	0.0102	0.0157	CcSEcCtD
Treprostinil—Angioedema—Varenicline—nicotine dependence	0.0101	0.0155	CcSEcCtD
Treprostinil—Malaise—Varenicline—nicotine dependence	0.00993	0.0153	CcSEcCtD
Treprostinil—Syncope—Varenicline—nicotine dependence	0.00988	0.0153	CcSEcCtD
Treprostinil—Palpitations—Varenicline—nicotine dependence	0.00973	0.015	CcSEcCtD
Treprostinil—Loss of consciousness—Varenicline—nicotine dependence	0.00968	0.015	CcSEcCtD
Treprostinil—Cough—Varenicline—nicotine dependence	0.00961	0.0149	CcSEcCtD
Treprostinil—Arthralgia—Varenicline—nicotine dependence	0.00938	0.0145	CcSEcCtD
Treprostinil—Chest pain—Varenicline—nicotine dependence	0.00938	0.0145	CcSEcCtD
Treprostinil—Myalgia—Varenicline—nicotine dependence	0.00938	0.0145	CcSEcCtD
Treprostinil—Anxiety—Varenicline—nicotine dependence	0.00935	0.0144	CcSEcCtD
Treprostinil—Discomfort—Varenicline—nicotine dependence	0.00927	0.0143	CcSEcCtD
Treprostinil—Oedema—Varenicline—nicotine dependence	0.00899	0.0139	CcSEcCtD
Treprostinil—Infection—Varenicline—nicotine dependence	0.00893	0.0138	CcSEcCtD
Treprostinil—Shock—Varenicline—nicotine dependence	0.00885	0.0137	CcSEcCtD
Treprostinil—Thrombocytopenia—Varenicline—nicotine dependence	0.0088	0.0136	CcSEcCtD
Treprostinil—Tachycardia—Varenicline—nicotine dependence	0.00877	0.0136	CcSEcCtD
Treprostinil—Anorexia—Varenicline—nicotine dependence	0.00857	0.0132	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00845	0.0655	CbGpPWpGaD
Treprostinil—Hypotension—Varenicline—nicotine dependence	0.0084	0.013	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00819	0.0127	CcSEcCtD
Treprostinil—Insomnia—Varenicline—nicotine dependence	0.00813	0.0126	CcSEcCtD
Treprostinil—Dyspnoea—Varenicline—nicotine dependence	0.00802	0.0124	CcSEcCtD
Treprostinil—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00795	0.0615	CbGpPWpGaD
Treprostinil—Dyspepsia—Varenicline—nicotine dependence	0.00791	0.0122	CcSEcCtD
Treprostinil—Decreased appetite—Varenicline—nicotine dependence	0.00782	0.0121	CcSEcCtD
Treprostinil—Fatigue—Varenicline—nicotine dependence	0.00775	0.012	CcSEcCtD
Treprostinil—Pain—Varenicline—nicotine dependence	0.00769	0.0119	CcSEcCtD
Treprostinil—Feeling abnormal—Varenicline—nicotine dependence	0.00741	0.0114	CcSEcCtD
Treprostinil—Gastrointestinal pain—Varenicline—nicotine dependence	0.00735	0.0114	CcSEcCtD
Treprostinil—Abdominal pain—Varenicline—nicotine dependence	0.00711	0.011	CcSEcCtD
Treprostinil—Body temperature increased—Varenicline—nicotine dependence	0.00711	0.011	CcSEcCtD
Treprostinil—Asthenia—Varenicline—nicotine dependence	0.00645	0.00996	CcSEcCtD
Treprostinil—Pruritus—Varenicline—nicotine dependence	0.00636	0.00983	CcSEcCtD
Treprostinil—Diarrhoea—Varenicline—nicotine dependence	0.00615	0.0095	CcSEcCtD
Treprostinil—Dizziness—Varenicline—nicotine dependence	0.00595	0.00918	CcSEcCtD
Treprostinil—Vomiting—Varenicline—nicotine dependence	0.00572	0.00883	CcSEcCtD
Treprostinil—Rash—Varenicline—nicotine dependence	0.00567	0.00876	CcSEcCtD
Treprostinil—Dermatitis—Varenicline—nicotine dependence	0.00566	0.00875	CcSEcCtD
Treprostinil—Headache—Varenicline—nicotine dependence	0.00563	0.0087	CcSEcCtD
Treprostinil—Nausea—Varenicline—nicotine dependence	0.00534	0.00825	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—TAS2R16—nicotine dependence	0.00512	0.0396	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—TAS2R16—nicotine dependence	0.00471	0.0365	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00356	0.0276	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00331	0.0256	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0033	0.0256	CbGpPWpGaD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00326	0.0252	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00304	0.0236	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00289	0.0224	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00283	0.0219	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00267	0.0207	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00266	0.0206	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—TAS2R16—nicotine dependence	0.00263	0.0203	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00261	0.0202	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—DRD2—nicotine dependence	0.00258	0.02	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TAS2R16—nicotine dependence	0.00242	0.0187	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—CCAR1—nicotine dependence	0.00241	0.0187	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00239	0.0185	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—FGD1—nicotine dependence	0.00227	0.0176	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0022	0.017	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—OPRM1—nicotine dependence	0.00216	0.0167	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—FGD1—nicotine dependence	0.00209	0.0162	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—FGD1—nicotine dependence	0.00206	0.016	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00205	0.0159	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—OPRM1—nicotine dependence	0.00199	0.0154	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—FGD1—nicotine dependence	0.0019	0.0147	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00189	0.0146	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—DRD2—nicotine dependence	0.00156	0.0121	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TAS2R16—nicotine dependence	0.00155	0.012	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00151	0.0117	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—DRD2—nicotine dependence	0.00144	0.0111	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TAS2R16—nicotine dependence	0.00143	0.0111	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00142	0.011	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0014	0.0109	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—OPRM1—nicotine dependence	0.00122	0.00945	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGD1—nicotine dependence	0.00122	0.00943	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP2A7—nicotine dependence	0.00121	0.00936	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—OPRM1—nicotine dependence	0.00112	0.00869	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGD1—nicotine dependence	0.00112	0.00868	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—OPRM1—nicotine dependence	0.00111	0.00858	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKR1B10—nicotine dependence	0.00108	0.00833	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—OPRM1—nicotine dependence	0.00102	0.00789	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKR1B10—nicotine dependence	0.00099	0.00767	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—DRD2—nicotine dependence	0.000882	0.00683	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—DRD2—nicotine dependence	0.000811	0.00628	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—DRD2—nicotine dependence	0.000801	0.0062	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—WASF2—nicotine dependence	0.000758	0.00587	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—DRD2—nicotine dependence	0.000737	0.00571	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—WASF1—nicotine dependence	0.000727	0.00563	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—WASF2—nicotine dependence	0.000697	0.0054	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—WASF1—nicotine dependence	0.000669	0.00518	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—OPRM1—nicotine dependence	0.000654	0.00507	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—OPRM1—nicotine dependence	0.000602	0.00466	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DRD2—nicotine dependence	0.000473	0.00366	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DRD2—nicotine dependence	0.000435	0.00337	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000243	0.00188	CbGpPWpGaD
